BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33927551)

  • 1. Comparison of hyaluronic acid in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus.
    Cylwik B; Gruszewska E; Gindzienska-Sieskiewicz E; Kowal-Bielecka O; Chrostek L
    Biochem Med (Zagreb); 2021 Jun; 31(2):020701. PubMed ID: 33927551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum concentration of hyaluronic acid in healthy populations and patients with rheumatoid arthritis--relationship to clinical disease activity of RA].
    Yoshinoya S; Mizoguchi Y; Hashimoto Y; Yamada A; Uchida S; Taniguchi A; Nishioka K; Miyamoto T
    Ryumachi; 1991 Aug; 31(4):381-90. PubMed ID: 1948454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate-deficient transferrin depends on disease activity in rheumatoid arthritis and systemic sclerosis.
    Gruszewska E; Chludzinska A; Chrostek L; Cylwik B; Gindzienska-Sieskiewicz E; Szmitkowski M; Sierakowski S
    Scand J Rheumatol; 2013; 42(3):203-6. PubMed ID: 23379548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases.
    Chrostek L; Cylwik B; Gindzienska-Sieskiewicz E; Gruszewska E; Szmitkowski M; Sierakowski S
    Rheumatol Int; 2014 Mar; 34(3):393-9. PubMed ID: 24346772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 polymorphisms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
    Louthrenoo W; Kasitanon N; Wongthanee A; Kuwata S; Takeuchi F
    Int J Rheum Dis; 2021 Nov; 24(11):1378-1385. PubMed ID: 34533895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
    Ribbens C; Martin y Porras M; Franchimont N; Kaiser MJ; Jaspar JM; Damas P; Houssiau FA; Malaise MG
    Ann Rheum Dis; 2002 Feb; 61(2):161-6. PubMed ID: 11796404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients.
    Keenan RT; Swearingen CJ; Yazici Y
    Clin Exp Rheumatol; 2008; 26(5):814-9. PubMed ID: 19032813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
    Becker-Merok A; Nikolaisen C; Nossent HC
    Lupus; 2006; 15(9):570-6. PubMed ID: 17080911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of Interleukin 29 in patients with rheumatoid arthritis and other rheumatic diseases.
    da Rocha Junior LF; Branco Pinto Duarte AL; de Melo Rêgo MJB; de Almeida AR; de Melo Vilar K; de Lima HD; Tavares Dantas A; de Ataíde Mariz H; da Rocha Pitta I; da Rocha Pitta MG
    Immunol Lett; 2020 Apr; 220():38-43. PubMed ID: 31954799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Newly Diagnosed Drug-Naive Patients with Systemic Autoimmune Diseases Revealed the Cleaved Peptide Tyrosine Tyrosine (PYY 3-36) as a Specific Plasma Biomarker of Rheumatoid Arthritis.
    Balog JA; Kemeny A; Puskas LG; Burcsar S; Balog A; Szebeni GJ
    Mediators Inflamm; 2021; 2021():5523582. PubMed ID: 34239365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.
    Park EH; Strand V; Oh YJ; Song YW; Lee EB
    Arthritis Res Ther; 2019 Feb; 21(1):61. PubMed ID: 30770765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CCP antibodies and rheumatoid factor in systemic sclerosis: Prevalence and relationships with joint manifestations.
    Wielosz E; Majdan M; Dryglewska M; Zwolak R
    Adv Clin Exp Med; 2018 Sep; 27(9):1253-1257. PubMed ID: 30024658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
    Louthrenoo W; Kasitanon N; Wichainun R; Wangkaew S; Sukitawut W; Kuwata S; Takeuchi F
    Clin Rheumatol; 2010 Mar; 29(3):241-6. PubMed ID: 20091076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Power of Galectin-3 in Rheumatic Diseases.
    Gruszewska E; Cylwik B; Gińdzieńska-Sieśkiewicz E; Kowal-Bielecka O; Mroczko B; Chrostek L
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33076422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.
    Emlen W; Niebur J; Flanders G; Rutledge J
    J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of common inflammatory markers in treatment-naïve patients with systemic rheumatic diseases.
    Kim MJ; Lee EB; Song YW; Park JK
    Clin Rheumatol; 2020 Oct; 39(10):2899-2906. PubMed ID: 32314175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders.
    Stuart RA; Littlewood AJ; Maddison PJ; Hall ND
    Clin Exp Rheumatol; 1995; 13(1):17-22. PubMed ID: 7774098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor in patients with rheumatoid arthritis.
    Harada M; Mitsuyama K; Yoshida H; Sakisaka S; Taniguchi E; Kawaguchi T; Ariyoshi M; Saiki T; Sakamoto M; Nagata K; Sata M; Matsuo K; Tanikawa K
    Scand J Rheumatol; 1998; 27(5):377-80. PubMed ID: 9808403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.